Unknown

Dataset Information

0

Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cells.

ABSTRACT: To identify the structural features of 9H-pyrimido[4,5-b]indoles as microtubule depolymerizers, pyrimido[4,5-b]indoles 2-8 with varied substituents at the 2-, 4- and 5-positions were designed and synthesized. Nucleophilic displacement of 2,5-substituted-4-chloro-pyrimido[4,5-b]indoles with appropriate arylamines was the final step employed in the synthesis of target compounds 2-8. Compounds 2 and 6 had two-digit nanomolar potency (IC50) against MDA-MB-435, SK-OV-3 and HeLa cancer cells in vitro. Compounds 2 and 6 also depolymerized microtubules comparable to the lead compound 1. Compounds 2, 3, 6 and 8 were effective in cells expressing P-glycoprotein or the ?III isotype of tubulin, mechanisms that are associated with clinical drug resistance to microtubule targeting drugs. Proton NMR and molecular modeling studies were employed to identify the structural basis for the microtubule depolymerizing activity of pyrimido[4,5-b]indoles.

SUBMITTER: Devambatla RKV 

PROVIDER: S-EPMC5603926 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cells.

Devambatla Ravi Kumar Vyas RKV   Li Wei W   Zaware Nilesh N   Choudhary Shruti S   Hamel Ernest E   Mooberry Susan L SL   Gangjee Aleem A  

Bioorganic & medicinal chemistry letters 20170527 15

To identify the structural features of 9H-pyrimido[4,5-b]indoles as microtubule depolymerizers, pyrimido[4,5-b]indoles 2-8 with varied substituents at the 2-, 4- and 5-positions were designed and synthesized. Nucleophilic displacement of 2,5-substituted-4-chloro-pyrimido[4,5-b]indoles with appropriate arylamines was the final step employed in the synthesis of target compounds 2-8. Compounds 2 and 6 had two-digit nanomolar potency (IC<sub>50</sub>) against MDA-MB-435, SK-OV-3 and HeLa cancer cell  ...[more]

Similar Datasets

Unknown Janus Compounds, 5-Chloro-N⁴-methyl-N⁴-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, Cause Both Microtubule Depolymerizing and Stabilizing Effects.
| S-EPMC5470396 | biostudies-literature
Unknown Synthesis of N(4)-(substituted phenyl)-N(4)-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells.
| S-EPMC3572549 | biostudies-literature
Unknown Sugar modified pyrimido[4,5-<i>b</i>]indole nucleosides: synthesis and antiviral activity.
| S-EPMC6084004 | biostudies-literature
Unknown Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance.
| S-EPMC5818492 | biostudies-literature
Unknown Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.
| S-EPMC5398096 | biostudies-literature
Unknown Synthesis and biological activity of 5-chloro-N⁴-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents.
| S-EPMC3602277 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of 7-Chloro-9H-pyrimido[4,5-b]indole-based Glycogen Synthase Kinase-3β Inhibitors.
| S-EPMC6630214 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents.
| S-EPMC3163380 | biostudies-literature
Unknown 4,5,8a-Triphenyl-perhydro-pyrimido[4,5-d]pyrimidine-2,7-dione monohydrate.
| S-EPMC2979643 | biostudies-literature
Unknown Preparation of tetrasubstituted pyrimido[4,5-<i>d</i>]pyrimidine diones.
| S-EPMC4829973 | biostudies-literature